Telix Pharmaceuticals Highlights $1B Revenue Track, Pixclara Resubmission, PSMA Growth at Oppenheimer Conf.

Telix Pharmaceuticals (NASDAQ:TLX) outlined its commercial imaging franchise, regulatory plans for two radiodiagnostic candidates, and progress across a broad therapeutic radiopharmaceutical pipeline ...
Pharmabiz

Bayer presents positive results from global phase I first-in-human, dose-escalation PAnTHa study at ASCO GU 2026

Bayer presents positive results from global phase I first-in-human, dose-escalation PAnTHa study at ASCO GU 2026: Berlin, Germany Monday, March 2, 2026, 13:00 Hrs [IST] Bayer anno ...

Johnson And Johnson Weighs Drug Breakthroughs Against Possible DePuy Synthes Sale

Johnson & Johnson (NYSE:JNJ) reported encouraging early clinical results for its prostate cancer therapy pasritamig and is preparing for Phase 3 trials. The company has submitted nipocalimab to the ...

Amgen Inc. (AMGN) Presents at TD Cowen 46th Annual Health Care Conference Transcript

TD Cowen 46th Annual Health Care Conference March 2, 2026 1:10 PM ESTCompany ParticipantsKave Niksefat - Senior Vice President of ...

Trump sparks new health fears as viewers spot 'nasty' issue on his NECK

WARNING GRAPHIC CONTENT: Donald Trump's neck was plagued by a painful-looking condition as he attended a medals ceremony on Monday at the White House.

RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide

Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for ...
The Manila Times

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) to be completed by our partner Jazz in first-line ...
Fierce Biotech

TCE biotech Candid scores Nasdaq listing via reverse merger with rare disease-focused Rallybio

T-cell engager (TCE) specialist Candid Therapeutics has entered a reverse merger agreement with Rallybio that will allow Candid to trade on the Nasdaq while dumping RallyBio’s rare disease maternal ...
TMCnet

GT Biopharma Reports Full Year 2025 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE ® continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating ...
Medindia

Stop Bladder Leaks With Simple Daily Strategies

Struggling with bladder leaks? Learn causes, pelvic floor exercises, and practical ways to manage urinary incontinence.
TMCnet

Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date

Lumexa Imaging will host a conference call to discuss its fourth quarter and full year 2025 financial results and 2026 outlook on March 26, 2026 at 8:30 a.m. ET.

GT Biopharma, Inc.: GT Biopharma Reports Full Year 2025 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE- continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating ...